NCT02840500

Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 101 (actual)
• Sponsor: Angelini Farmacéutica · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Patients treated in Palliative Care Units are potentially fragile patients, especially in our case, which are cancer patients. The management of these patients is usually done from experience, because these patients rarely meet criteria for clinical trials, as their inclusion could affect results obtained in the trial. There is insufficient clinical information on the quality of life of cancer patients with breakthrough pain treated in palliative care units according to routine clinical practice. For this reason we consider it is appropriate to prospectively evaluate the quality of life of cancer patients with cancer breakthrough pain treated in palliative care units as well as the characteristics of these patients. This post-authorization observational study will assess the quality of life of patients with breakthrough cancer pain treated in Palliative Care Units in Spanish hospitals.

Conditions

• Breakthrough Pain

Interventions

Type	Name	Description
OTHER	No intervention	No intervention

Timeline

• Start date: 2016-06-27
• Primary completion: 2017-12-01
• Completion: 2018-03-01
• First posted: 2016-07-21
• Last updated: 2018-03-05

Locations

10 sites across 1 country: Spain